Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

0ELV

Guerbet (0ELV)

Guerbet Sa
Von:
Sortieren nach:
 Showing the most relevant articles for your search:LSE:0ELV
DatumZeitQuelleÜberschriftSymbolFirma
18/03/202411h37UK RegulatoryGUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 29 février 2024LSE:0ELVGuerbet Sa
19/02/202417h46UK RegulatoryGUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2024LSE:0ELVGuerbet Sa
11/12/202317h45PR Newswire (US)Guerbet announces marketing authorisation approval of Elucirem™ (Gadopiclenol) in the European UnionLSE:0ELVGuerbet Sa
21/09/202219h08PR Newswire (US)Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol)LSE:0ELVGuerbet Sa
13/06/202208h30PR Newswire (US)Guerbet receives EMA acceptance of Elucirem™ as the Brand Name for GadopiclenolLSE:0ELVGuerbet Sa
07/03/202218h00PR Newswire (US)Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolizationLSE:0ELVGuerbet Sa
07/03/202218h00PR Newswire (US)Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolizationLSE:0ELVGuerbet Sa
 Showing the most relevant articles for your search:LSE:0ELV

Kürzlich von Ihnen besucht

Delayed Upgrade Clock